Nextage Therapeutics Ltd (TLV:NXTG)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
90.80
-4.90 (-5.12%)
Aug 13, 2025, 5:24 PM IDT
67.53%
Market Cap 30.60M
Revenue (ttm) 413.00K
Net Income (ttm) -3.28M
Shares Out 33.70M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,327
Average Volume 35,209
Open 95.70
Previous Close 95.70
Day's Range 90.00 - 96.00
52-Week Range 54.20 - 119.00
Beta 0.26
RSI 41.82
Earnings Date Aug 28, 2025

About Nextage Therapeutics

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products. The company was formerly known as Nextage Cannabis Innovation Ltd. and changed its name to Nextage Therapeutics Ltd in August 2020. The company was incorporated in 1982 and is based in Ness Ziona, Israel. [Read more]

Sector Healthcare
Founded 1982
Employees 31
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol NXTG
Full Company Profile

Financial Performance

In 2024, Nextage Therapeutics's revenue was 413,000, a decrease of -52.85% compared to the previous year's 876,000. Losses were -3.28 million, -15.36% less than in 2023.

Financial Statements

News

There is no news available yet.